Singapore markets close in 4 hours 13 minutes
Straits Times Index
3,201.75 -3.39 (-0.11%) Nikkei
28,566.89 -237.96 (-0.83%) Hang Seng
26,150.24 +23.31 (+0.09%) FTSE 100
7,204.55 +14.25 (+0.20%) BTC-USD
61,978.78 +948.98 (+1.55%) CMC Crypto 200
1,453.34 -49.70 (-3.31%)
Emergent BioSolutions Inc. (EBS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
49.85-0.74 (-1.46%)
At close: 4:00PM EDT
| Previous close | 50.59 |
| Open | 50.20 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 49.50 - 50.76 |
| 52-week range | 49.35 - 127.20 |
| Volume | 336,713 |
| Avg. volume | 392,115 |
| Market cap | 2.677B |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | 9.06 |
| EPS (TTM) | 5.50 |
| Earnings date | 04 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 85.71 |
- Business Wire
Shuman, Glenn & Stecker Investigates Emergent BioSolutions, Inc.
DENVER, September 21, 2021--Shuamn, Glenn & Stecker investigates Emergent BioSolutions, Inc. (NYSE: EBS).
- Zacks
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Zacks
Emergent (EBS) Inks COVID-19 Manufacturing Deal With Providence
Emergent (EBS) is set to provide manufacturing services for doses of Providence Therapeutics' COVID-19 vaccine candidate as well as for its bulk drug substance.
© 2021 Verizon Media. All rights reserved.
